Simon PLYTE, PhD
Chief Scientific Officer (CSO) and member of the Scientific Advisory Board (SAB)
Simon Plyte is the Chief Scientific Officer of BIOMUNEX and has over 20 years of experience at the Director/VP level in the Pharmaceutical industry. He has a proven track record of successful drug discovery and development of both NCEs and biologics in oncology and other therapeutic areas. Simon has worked in both big Pharma (Pharmacia, Boehringer-Ingelheim) and small biotech (e.g. Nerviano Medical Sciences and Congenia) in Germany, Italy, Switzerland and the Netherlands. Further Simon worked as Senior Director and Vice President Immuno-Oncology at publicly traded biotechnology companies developing bi-/multi-specific biotherapeutics: Molecular Partners AG (Zürich Area, Switzerland) and Merus (Utrecht Area, Netherlands). Prior to entering the pharmaceutical industry Simon was a Post-doctoral fellow at the Ludwig Institute for Cancer Research (London, UK) and the Ontario Cancer Institute (Toronto Canada) and is the co-author of several publications and patents. He holds a PhD in Biochemistry and Biophysics from University of Portsmouth (UK).